๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Thermodynamic analysis of hydrogen solubility in graphite

โœ Scribed by Yoshirou Shirasu; Shinsuke Yamanaka; Masanobu Miyake


Book ID
107810737
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
459 KB
Volume
200
Category
Article
ISSN
0022-3115

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Solubility of hydrogen isotopes in graph
โœ Yoshirou Shirasu; Shinsuke Yamanaka; Masanobu Miyake ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 338 KB
Hydrogen adsorption on and solubility in
โœ S.L. Kanashenko; A.E. Gorodetsky; V.N. Chernikov; A.V. Markin; A.P. Zakharov; B. ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 406 KB
The thermodynamics and solubility of hyd
โœ Z.R. Xu; R.B. McLellan ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 71 KB

The solubility of hydrogen in FeAl in equilibrium with gas as a constant pressure was measured in the temperature range 513-1301 K. The solubility data have been analyzed in terms of a statistical model in which the interstitial atoms are distributed through the three distinct sites in the B2 lattic

Thermodynamics of hydrogen solubility in
โœ M. Orentlicher; J.M. Prausnitz ๐Ÿ“‚ Article ๐Ÿ“… 1964 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 686 KB

Solubility data for hydrogen in liquids at low temperature and high pressure have been reduced by a thermodynamic relation similar to the Krichevsky-Kasamovsky equation but allowing for the variation of activity coefficient with hydrogen concentration. The parameters appearing in this relation have

Solubility advantage of amorphous pharma
โœ Sharad B. Murdande; Michael J. Pikal; Ravi M. Shanker; Robin H. Bogner ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 211 KB ๐Ÿ‘ 1 views

In recent years there has been growing interest in advancing amorphous pharmaceuticals as an approach for achieving adequate solubility. Due to difficulties in the experimental measurement of solubility, a reliable estimate of the solubility enhancement ratio of an amorphous form of a drug relative